Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Total Current Liabilities (2016 - 2025)

National Research (NRC) has disclosed Total Current Liabilities for 16 consecutive years, with $36.6 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 2.13% to $36.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.6 million through Dec 2025, up 2.13% year-over-year, with the annual reading at $36.6 million for FY2025, 2.13% up from the prior year.
  • Total Current Liabilities hit $36.6 million in Q4 2025 for National Research, down from $38.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $48.8 million in Q1 2024 to a low of $33.4 million in Q4 2022.
  • Historically, Total Current Liabilities has averaged $39.1 million across 5 years, with a median of $38.9 million in 2021.
  • Biggest five-year swings in Total Current Liabilities: surged 35.55% in 2024 and later decreased 22.67% in 2025.
  • Year by year, Total Current Liabilities stood at $40.4 million in 2021, then fell by 17.26% to $33.4 million in 2022, then rose by 8.34% to $36.2 million in 2023, then dropped by 0.95% to $35.9 million in 2024, then grew by 2.13% to $36.6 million in 2025.
  • Business Quant data shows Total Current Liabilities for NRC at $36.6 million in Q4 2025, $38.6 million in Q3 2025, and $35.9 million in Q2 2025.